Literature DB >> 10502271

Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus.

K Johansen1, J Hinkula, F Espinoza, M Levi, C Zeng, U Rudén, T Vesikari, M Estes, L Svensson.   

Abstract

Rotavirus nonstructural protein NSP4 has recently been suggested to function as a viral enterotoxin and play a role in the pathophysiological mechanism whereby rotaviruses induce diarrhea. The ability of rotavirus NSP4 to stimulate a humoral immune response was examined in naturally infected children and adults, rotavirus vaccinated children, as well as a cellular immune response in adults. In this study, 10 of 10 naturally infected children and 9 of 10 rotavirus-vaccinated children showed a weak humoral IgG immune response to recombinant NSP4 (rNSP4) and/or a synthetic peptide corresponding to residues 114-134 of NSP4. Modest serum IgG antibody responses were detected in 20 of 20 adults. A cellular immune response to rNSP4 and/or NSP4(114-134) were detected in 8 of 10 adults measured either as a T-cell proliferative response (7 of 10), an increased production of IL-2 (6 of 10), or increased production of interferon-gamma (8 of 10). These results indicate that NSP4 induces a humoral immune response in humans and show for the first time that NSP4 stimulates a cellular immune response, possibly including cytolytic T-cells. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502271

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

Review 1.  Why should a clinician care about the molecular biology of transport?

Authors:  A J Janecki
Journal:  Curr Gastroenterol Rep       Date:  2000-10

2.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

3.  Higher Expression Level and Lower Toxicity of Genetically Spliced Rotavirus NSP4 in Comparison to the Full-Length Protein in E. coli.

Authors:  Mehdi Sahmani; Siavash Azari; Majid Tebianian; Nematollah Gheibi; Farzaneh Pourasgari
Journal:  Iran J Biotechnol       Date:  2016-06       Impact factor: 1.671

4.  Antibody-secreting cell responses to rotavirus proteins in gnotobiotic pigs inoculated with attenuated or virulent human rotavirus.

Authors:  K O Chang; O H Vandal; L Yuan; D C Hodgins; L J Saif
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.

Authors:  Esmeralda Vizzi; Eva Calviño; Rosabel González; Irene Pérez-Schael; Max Ciarlet; Gagandeep Kang; Mary K Estes; Ferdinando Liprandi; Juan E Ludert
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

6.  Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015-2016, with cogent genes of the Rotarix and RotaTeq vaccine strains.

Authors:  O V Morozova; T A Sashina; N V Epifanova; V V Zverev; A U Kashnikov; N A Novikova
Journal:  Virus Genes       Date:  2017-12-13       Impact factor: 2.332

7.  Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3.

Authors:  Max Ciarlet; Joseph M Hyser; Mary K Estes
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

8.  Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato.

Authors:  T-G Kim; W H R Langridge
Journal:  Plant Cell Rep       Date:  2003-10-10       Impact factor: 4.570

9.  Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato.

Authors:  T-G Kim; W H R Langridge
Journal:  Plant Cell Rep       Date:  2003-03-22       Impact factor: 4.570

Review 10.  Rotavirus vaccines and pathogenesis: 2008.

Authors:  Joseph M Hyser; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2009-01       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.